Published in AJNR Am J Neuroradiol on April 01, 2003
Anatomic results and complications of stent-assisted coil embolization of intracranial aneurysms. Interv Neuroradiol (2008) 0.89
Endovascular treatment of ACom intracranial aneurysms. Report on series of 280 patients. Interv Neuroradiol (2010) 0.86
Ultra-early surgery for poor-grade intracranial aneurysmal subarachnoid hemorrhage: a preliminary study. Yonsei Med J (2009) 0.78
Endovascular treatment of ruptured intracranial aneurysms in patients 70 years of age and older. Surg Neurol Int (2014) 0.77
Trends over time in the management of 2253 patients with cerebral aneurysms: A single practice experience. Surg Neurol Int (2011) 0.77
Long-term domain-specific improvement following poor grade aneurysmal subarachnoid hemorrhage. J Neurol (2006) 0.76
Follow-up of Large Aneurysms Treated with Coil Embolization at an Acute Stage in Patients with Poor-Grade Subarachnoid Hemorrhage. Interv Neuroradiol (2009) 0.75
Acute management of poor condition subarachnoid hemorrhage patients. Vasc Health Risk Manag (2007) 0.75
Comparison of endovascular coiling and surgical clipping for the treatment of intracranial aneurysms: A prospective study. Iran J Neurol (2015) 0.75
Coil Embolization of Aneurysm Followed by Stereotactic Aspiration of Hematoma in a Patient with Anterior Communicating Artery Aneurysm Presenting with SAH and ICH. J Korean Neurosurg Soc (2008) 0.75
Early treatment for ruptured cerebral aneurysms. Location of aneurysms and choice of treatments. Interv Neuroradiol (2008) 0.75
Emergent management of ruptured pericallosal-callosomarginal artery aneurysm using stent-assisted coil embolization. Emerg Radiol (2006) 0.75
Ultra-early versus delayed coil treatment for ruptured poor-grade aneurysm. Neuroradiology (2014) 0.75
Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol (2006) 10.51
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke (2005) 8.05
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol (2012) 5.91
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A (2012) 4.20
Arteriovenous malformations. Lancet (2002) 3.15
Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg (2005) 2.87
Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke (2008) 2.57
Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci (2005) 2.53
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab (2006) 2.41
Cell transplantation therapy for stroke. Stroke (2007) 2.30
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain (2011) 2.27
Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol (2006) 2.17
Sex differences in clinical presentation and treatment outcomes in Moyamoya disease. Neurosurgery (2012) 2.06
Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A (2007) 2.03
Prospective analysis of clinical outcomes after percutaneous vertebroplasty for painful osteoporotic vertebral body fractures. AJNR Am J Neuroradiol (2005) 2.00
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet (2008) 1.95
Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab (2008) 1.86
Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus (2008) 1.84
Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke (2006) 1.83
Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci (2004) 1.71
Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem (2003) 1.69
Line scan diffusion imaging of the spine. AJNR Am J Neuroradiol (2003) 1.61
Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis (2009) 1.61
Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant (2009) 1.60
Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab (2008) 1.59
Multimodality treatment of posterior fossa arteriovenous malformations. J Neurosurg (2008) 1.59
General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage. J Cereb Blood Flow Metab (2007) 1.57
The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem (2008) 1.54
Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke (2005) 1.54
Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells (2011) 1.54
Comparison of the response to endovascular reperfusion in relation to site of arterial occlusion. Neurology (2013) 1.51
Spinal pilocytic astrocytoma in an elderly patient. World Neurosurg (2011) 1.49
Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke (2008) 1.44
Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke (2010) 1.44
Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis (2006) 1.40
Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One (2008) 1.37
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology (2014) 1.36
Bcl-2 transfection via herpes simplex virus blocks apoptosis-inducing factor translocation after focal ischemia in the rat. J Cereb Blood Flow Metab (2004) 1.36
Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg (2009) 1.35
Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke (2011) 1.34
Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther (2009) 1.34
Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell (2010) 1.32
Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci U S A (2011) 1.32
Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke (2007) 1.29
Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade. J Cereb Blood Flow Metab (2002) 1.21
Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol (2005) 1.20
The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Stroke (2008) 1.18
Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia. J Cereb Blood Flow Metab (2007) 1.17
Paradoxical cerebral herniation secondary to lumbar puncture after decompressive craniectomy for a large space-occupying hemispheric stroke: case report. Neurosurgery (2005) 1.16
Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods (2011) 1.16
New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya. Curr Neurovasc Res (2006) 1.14
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 1.13
Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Ann Neurol (2002) 1.12
Biphasic cytochrome c release after transient global ischemia and its inhibition by hypothermia. J Cereb Blood Flow Metab (2005) 1.12
DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res (2007) 1.11
Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus (2009) 1.10
Multimodality treatment of giant intracranial arteriovenous malformations. Neurosurgery (2003) 1.10
Evaluation of surgical techniques for neuronal cell transplantation used in patients with stroke. Cell Transplant (2004) 1.09
Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR. Stroke (2009) 1.09
Wherefore Wingspan? AJNR Am J Neuroradiol (2007) 1.08
Combined arterial spin label and dynamic susceptibility contrast measurement of cerebral blood flow. Magn Reson Med (2010) 1.08
Deep arteriovenous malformations of the basal ganglia and thalamus: natural history. J Neurosurg (2003) 1.08
Intravascular cell replacement therapy for stroke. Neurosurg Focus (2008) 1.07
Diffusion-weighted MR imaging in acute ischemia: value of apparent diffusion coefficient and signal intensity thresholds in predicting tissue at risk and final infarct size. AJNR Am J Neuroradiol (2004) 1.06
Truly hybrid X-ray/MR imaging: toward a streamlined clinical system. Acad Radiol (2005) 1.06
Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods (2008) 1.06
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol (2013) 1.05
The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke (2011) 1.05
Surgical and endovascular management of symptomatic posterior circulation fusiform aneurysms. J Neurosurg (2007) 1.05
Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. Exp Neurol (2004) 1.04
Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery (2008) 1.04
Stem cells and stroke: opportunities, challenges and strategies. Expert Opin Biol Ther (2011) 1.04
epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury. Neurosci Lett (2008) 1.04
Pathophysiology and genetic factors in moyamoya disease. Neurosurg Focus (2009) 1.04
Neurocognitive impairment in adults with moyamoya disease without stroke. Neurosurgery (2012) 1.03
Cavernous malformation of brainstem, thalamus, and basal ganglia: a series of 176 patients. Neurosurgery (2013) 1.03
N-butyl cyanoacrylate glue embolization of splenic artery aneurysms. J Vasc Interv Radiol (2004) 1.03
Conditions of protection by hypothermia and effects on apoptotic pathways in a rat model of permanent middle cerebral artery occlusion. J Neurosurg (2007) 1.03